(Q37303915)

19 August 2017

0 references

Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study (English)

1 reference

19 August 2017

cardiovascular disease

1 reference

20

1 reference

19 August 2017

44

1 reference

19 August 2017

Hugh Christian Watkins

71

1 reference

19 August 2017

74

Daniel Teupser

0 references

André Uitterlinden

53

André G Uitterlinden

0 references

Pim van der Harst

89

Pim van der Harst

1 reference

19 August 2017

54

Vera Adamkova

1 reference

19 August 2017

82

Debbie A Lawlor

0 references

Ulf de Faire

33

Ulf de Faire

1 reference

19 August 2017

101

Mika Kivimaki

0 references

Anders Franco-Cereceda

47

Anders Franco-Cereceda

0 references

Dietrich Rothenbacher

26

Dietrich Rothenbacher

0 references

Dhayana Dallmeier

46

Dhayana Dallmeier

1 reference

19 August 2017

Montse Guardiola

6

0 references

Daniel I. Swerdlow

Daniel I Swerdlow

27

0 references

Damiano Baldassarre

Damiano Baldassarre

36

0 references

Wilko Spiering

Wilko Spiering

59

0 references

Tom Palmer

Tom M Palmer

106

0 references

Lasse Folkersen

Lasse Folkersen

4

0 references

Meena Kumari

Meena Kumari

61

0 references

Tabassome Simon

Tabassome Simon

2

0 references

Folkert Asselbergs

Folkert W Asselbergs

5

0 references

Philippa Talmud

Philippa J Talmud

113

0 references

Alistair Scott Hall

Alistair S Hall

65

0 references

Stephen E Humphries

Steve E Humphries

103

0 references

Per Eriksson

Per Eriksson

107

0 references

Tom R. Gaunt

Tom R Gaunt

77

0 references

Ziad Mallat

Ziad Mallat

111

0 references

Peter H. Whincup

Peter H Whincup

62

0 references

Elena Tremoli

Elena Tremoli

35

0 references

Richard W. Morris

Richard W Morris

83

0 references

Oscar H Franco

Oscar H Franco

94

0 references

Alain Tedgui

51

Alain Tedgui

1 reference

19 August 2017

22

Salma Kotti

1 reference

19 August 2017

Guillaume Paré

108

0 references

Peter de Knijff

Peter de Knijff

96

0 references

Martin D Tobin

Martin D Tobin

69

0 references

Aroon Hingorani

109

Aroon D Hingorani

1 reference

19 August 2017

Christopher P Nelson

21

0 references

Anne Tybjærg-Hansen

97

Anne Tybjaerg-Hansen

1 reference

19 August 2017

87

Kay-Tee Khaw

1 reference

19 August 2017

100

Nilesh J Samani

1 reference

19 August 2017

45

Joachim Thiery

1 reference

19 August 2017

79

Naveed Sattar

1 reference

19 August 2017

17

Stella Trompet

1 reference

19 August 2017

70

Anders Hamsten

1 reference

19 August 2017

52

Albert Hofman

1 reference

19 August 2017

72

Wolfgang Koenig

1 reference

19 August 2017

80

Sotirios Tsimikas

1 reference

19 August 2017

92

Salim Yusuf

1 reference

19 August 2017

95

J Wouter Jukema

1 reference

19 August 2017

Karoline Kuchenbaecker

28

Karoline B Kuchenbaecker

1 reference

19 August 2017

90

Jackie F Price

1 reference

19 August 2017

1

Michael V Holmes

1 reference

19 August 2017

9

Jaroslav A Hubacek

1 reference

19 August 2017

34

Andrie G Panayiotou

1 reference

19 August 2017

41

Gerjan J Navis

1 reference

19 August 2017

60

Olaf H Klungel

1 reference

19 August 2017

67

Pieter A Doevendans

1 reference

19 August 2017

88

Brendan J Keating

1 reference

19 August 2017

19

G Kees Hovingh

1 reference

19 August 2017

84

Manjinder S Sandhu

1 reference

19 August 2017

8

Jutta Palmen

1 reference

19 August 2017

57

Maarten J Cramer

1 reference

19 August 2017

37

Fabrizio Veglia

1 reference

19 August 2017

16

Maarten Leusink

1 reference

19 August 2017

48

Jolanda M A Boer

1 reference

19 August 2017

N Charlotte Onland-Moret

56

N Charlotte Onland-Moret

1 reference

19 August 2017

42

Irene Mateo Leach

1 reference

19 August 2017

64

Peter S Braund

1 reference

19 August 2017

98

Daniel J Rader

1 reference

19 August 2017

24

Markus Scholz

1 reference

19 August 2017

39

Frank Beutner

1 reference

19 August 2017

30

Anuj Goel

1 reference

19 August 2017

68

Mieke D Trip

1 reference

19 August 2017

13

Jessica L Mega

1 reference

19 August 2017

110

Marc S Sabatine

1 reference

19 August 2017

14

Erik P A van Iperen

1 reference

19 August 2017

105

S Matthijs Boekholdt

1 reference

19 August 2017

11

Benjamin D Horne

1 reference

19 August 2017

32

Karl Gertow

1 reference

19 August 2017

38

Lesca M Holdt

1 reference

19 August 2017

Jacqueline C M Witteman

93

Jaqueline C M Witteman

1 reference

19 August 2017

99

Martin Farrall

1 reference

19 August 2017

Ferdinand M Van't Hooft

31

Ferdinand van 't Hooft

1 reference

19 August 2017

3

Holly J Exeter

1 reference

19 August 2017

78

Ian Ford

1 reference

19 August 2017

Jackie A Cooper

7

1 reference

19 August 2017

Kathryn F Carruthers

10

1 reference

19 August 2017

Kimberly D Brunisholz

12

1 reference

19 August 2017

Mingyao Li

15

1 reference

19 August 2017

Jeffrey J W Verschuren

18

1 reference

19 August 2017

Nicolas Danchin

23

1 reference

19 August 2017

Christiane L Haase

25

1 reference

19 August 2017

Eleonora Staines-Urias

29

1 reference

19 August 2017

Ron T Gansevoort

40

1 reference

19 August 2017

Lutz P Breitling

43

1 reference

19 August 2017

Jeffrey W Stephens

49

1 reference

19 August 2017

Marten H Hofker

50

1 reference

19 August 2017

Jan Pitha

55

1 reference

19 August 2017

Hendrik M Nathoe

58

1 reference

19 August 2017

David A Morrow

63

1 reference

19 August 2017

Anders G Olsson

66

1 reference

19 August 2017

Andrew N Nicolaides

73

1 reference

19 August 2017

Ian N M Day

75

1 reference

19 August 2017

John F Carlquist

76

1 reference

19 August 2017

Gregory G Schwartz

81

1 reference

19 August 2017

Rudolf Poledne

85

1 reference

19 August 2017

Anke H Maitland-van der Zee

86

1 reference

19 August 2017

Shamir R Mehta

91

1 reference

19 August 2017

Keith A A Fox

102

1 reference

19 August 2017

Jeffrey L Anderson

104

1 reference

19 August 2017

Juan P Casas

112

1 reference

19 August 2017

language of work or name

English

0 references

publication date

31 July 2013

1 reference

Journal of the American College of Cardiology

19 August 2017

1 reference

19 August 2017

62

1 reference

19 August 2017

21

1 reference

19 August 2017

1966-1976

1 reference

Phospholipase A2 enzymes and the risk of atherosclerosis

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826105

Genetic basis of blood pressure and hypertension

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826105

Prognostic utility of secretory phospholipase A(2) in patients with stable coronary artery disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826105

Identification, replication, and functional fine-mapping of expression quantitative trait loci in primary human liver tissue

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826105

Lipoprotein-associated and secreted phospholipases A₂ in cardiovascular disease: roles as biological effectors and biomarkers.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826105

The sPLA2 Inhibition to Decrease Enzyme Release after Percutaneous Coronary Intervention (SPIDER-PCI) trial.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826105

Randomized trial of an inhibitor of secretory phospholipase A2 on atherogenic lipoprotein subclasses in statin-treated patients with coronary heart disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826105

Effects of Varespladib Methyl on Biomarkers and Major Cardiovascular Events in Acute Coronary Syndrome Patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826105

Biological, clinical and population relevance of 95 loci for blood lipids

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826105

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826105

Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826105

Varespladib (A-002), a secretory phospholipase A2 inhibitor, reduces atherosclerosis and aneurysm formation in ApoE-/- mice

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826105

Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826105

Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826105

Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPI.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826105

Phospholipase A2 enzymes, high-dose atorvastatin, and prediction of ischemic events after acute coronary syndromes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826105

Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women: the EPIC-Norfolk study

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826105

Tagging-SNP haplotype analysis of the secretory PLA2IIa gene PLA2G2A shows strong association with serum levels of sPLA2IIa: results from the UDACS study

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826105

Macrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stress

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826105

Meta-analysis of genetic studies using Mendelian randomization--a multivariate approach

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826105

An integrated approach to the meta-analysis of genetic association studies using Mendelian randomization

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826105

Re: Estimation of Bias in Nongenetic Observational Studies Using “Mendelian Triangulation” by Bautista et al

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3826105

Inhibition of secretory phospholipase A(2) in patients with acute coronary syndromes: rationale and design of the vascular inflammation suppression to treat acute coronary syndrome for 16 weeks (VISTA-16) trial

3 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23916927

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23916927

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.JACC.2013.06.044

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

23916927

1 reference